Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

Clinical trial NCT00032786 · COMPLETED

Trial details

NCT number: NCT00032786
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2002-03-01
Primary completion: 2004-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.